BIOMAT Database Logo BIOMAT Database Logo

Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q. 1998

O van der Heijden, and H C Chiu, and T C Park, and H Takahashi, and V A LiVolsi, and J I Risinger, and J C Barrett, and A Berchuck, and A C Evans, and K Behbakht, and A W Menzin, and P C Liu, and I Benjamin, and M A Morgan, and S A King, and S C Rubin, and J Boyd
Department of Obstetrics and Gynecology, University of Pennsylvania Medical Center, Philadelphia, USA.

Uterine leiomyoma is a benign smooth muscle tumor of the myometrium and is the most commonly encountered neoplasm in women of reproductive age. As for most benign tumors, the pathogenesis of leiomyoma remains obscure, especially at the molecular genetic level. The purpose of this study was to perform a genome-wide allelotype analysis to identify potential sites of tumor suppressor gene inactivation. Fifty-two cases of uterine leiomyoma were subjected to allelotype analysis by using matched pairs of tumor and blood DNA. Loss of heterozygosity (LOH) was assessed at 61 microsatellite markers distributed throughout the genome and representing all 41 chromosome arms. In general, LOH was very rare except on chromosome 7q, where LOH was observed in 34% of all informative tumors. Fine-deletion mapping with 25 microsatellite markers from the 7q22 region revealed a minimal deletion unit of approximately 4 cM, bounded by the markers D7S2453 proximally and D7S496 distally, that probably harbors a novel tumor suppressor gene involved in the etiology of this tumor.

UI MeSH Term Description Entries
D007889 Leiomyoma A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues. Fibroid,Fibroid Tumor,Fibroid Uterus,Fibroids, Uterine,Fibroma, Uterine,Fibromyoma,Leiomyoma, Uterine,Fibroid Tumors,Fibroid, Uterine,Fibroids,Fibromas, Uterine,Fibromyomas,Leiomyomas,Tumor, Fibroid,Tumors, Fibroid,Uterine Fibroid,Uterine Fibroids,Uterine Fibroma,Uterine Fibromas,Uterus, Fibroid
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002897 Chromosomes, Human, Pair 7 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 7
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm
D016147 Genes, Tumor Suppressor Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible. Antioncogenes,Cancer Suppressor Genes,Emerogenes,Genes, Cancer Suppressor,Genes, Growth Suppressor,Genes, Metastasis Suppressor,Growth Suppressor Genes,Metastasis Suppressor Genes,Tumor Suppressor Genes,Anti-Oncogenes,Genes, Onco-Suppressor,Oncogenes, Recessive,Tumor Suppressing Genes,Anti Oncogenes,Anti-Oncogene,Antioncogene,Cancer Suppressor Gene,Emerogene,Gene, Cancer Suppressor,Gene, Growth Suppressor,Gene, Metastasis Suppressor,Gene, Onco-Suppressor,Gene, Tumor Suppressing,Gene, Tumor Suppressor,Genes, Onco Suppressor,Genes, Tumor Suppressing,Growth Suppressor Gene,Metastasis Suppressor Gene,Onco-Suppressor Gene,Onco-Suppressor Genes,Oncogene, Recessive,Recessive Oncogene,Recessive Oncogenes,Suppressor Gene, Cancer,Suppressor Gene, Growth,Suppressor Gene, Metastasis,Suppressor Genes, Cancer,Suppressor Genes, Growth,Suppressor Genes, Metastasis,Tumor Suppressing Gene,Tumor Suppressor Gene

Related Publications

O van der Heijden, and H C Chiu, and T C Park, and H Takahashi, and V A LiVolsi, and J I Risinger, and J C Barrett, and A Berchuck, and A C Evans, and K Behbakht, and A W Menzin, and P C Liu, and I Benjamin, and M A Morgan, and S A King, and S C Rubin, and J Boyd
Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q.
February 1996, Cancer research,
O van der Heijden, and H C Chiu, and T C Park, and H Takahashi, and V A LiVolsi, and J I Risinger, and J C Barrett, and A Berchuck, and A C Evans, and K Behbakht, and A W Menzin, and P C Liu, and I Benjamin, and M A Morgan, and S A King, and S C Rubin, and J Boyd
Mapping of a breast cancer tumor suppressor gene locus to a 4-cM interval on chromosome 18q21.
October 1997, Japanese journal of cancer research : Gann,
O van der Heijden, and H C Chiu, and T C Park, and H Takahashi, and V A LiVolsi, and J I Risinger, and J C Barrett, and A Berchuck, and A C Evans, and K Behbakht, and A W Menzin, and P C Liu, and I Benjamin, and M A Morgan, and S A King, and S C Rubin, and J Boyd
Refined localization of the cerebral cavernous malformation gene (CCM1) to a 4-cM interval of chromosome 7q contained in a well-defined YAC contig.
November 1995, Genome research,
O van der Heijden, and H C Chiu, and T C Park, and H Takahashi, and V A LiVolsi, and J I Risinger, and J C Barrett, and A Berchuck, and A C Evans, and K Behbakht, and A W Menzin, and P C Liu, and I Benjamin, and M A Morgan, and S A King, and S C Rubin, and J Boyd
Chromosome analysis of uterine adenomyosis. Detection of the leiomyoma-associated del(7q) in three cases.
April 1995, Cancer genetics and cytogenetics,
O van der Heijden, and H C Chiu, and T C Park, and H Takahashi, and V A LiVolsi, and J I Risinger, and J C Barrett, and A Berchuck, and A C Evans, and K Behbakht, and A W Menzin, and P C Liu, and I Benjamin, and M A Morgan, and S A King, and S C Rubin, and J Boyd
Localization of a putative tumor suppressor gene in the sub-telomeric region of chromosome 8p.
April 1999, Oncogene,
O van der Heijden, and H C Chiu, and T C Park, and H Takahashi, and V A LiVolsi, and J I Risinger, and J C Barrett, and A Berchuck, and A C Evans, and K Behbakht, and A W Menzin, and P C Liu, and I Benjamin, and M A Morgan, and S A King, and S C Rubin, and J Boyd
Putative tumor suppressor gene region within 0.85 cM on chromosome 12 in radiation-induced murine lymphomas.
July 1998, Molecular carcinogenesis,
O van der Heijden, and H C Chiu, and T C Park, and H Takahashi, and V A LiVolsi, and J I Risinger, and J C Barrett, and A Berchuck, and A C Evans, and K Behbakht, and A W Menzin, and P C Liu, and I Benjamin, and M A Morgan, and S A King, and S C Rubin, and J Boyd
Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.
October 1995, Oncogene,
O van der Heijden, and H C Chiu, and T C Park, and H Takahashi, and V A LiVolsi, and J I Risinger, and J C Barrett, and A Berchuck, and A C Evans, and K Behbakht, and A W Menzin, and P C Liu, and I Benjamin, and M A Morgan, and S A King, and S C Rubin, and J Boyd
Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
July 2005, Fertility and sterility,
O van der Heijden, and H C Chiu, and T C Park, and H Takahashi, and V A LiVolsi, and J I Risinger, and J C Barrett, and A Berchuck, and A C Evans, and K Behbakht, and A W Menzin, and P C Liu, and I Benjamin, and M A Morgan, and S A King, and S C Rubin, and J Boyd
Familial cerebral cavernous angioma: a gene localized to a 15-cM interval on chromosome 7q.
June 1996, Annals of neurology,
O van der Heijden, and H C Chiu, and T C Park, and H Takahashi, and V A LiVolsi, and J I Risinger, and J C Barrett, and A Berchuck, and A C Evans, and K Behbakht, and A W Menzin, and P C Liu, and I Benjamin, and M A Morgan, and S A King, and S C Rubin, and J Boyd
Localization of an autosomal dominant retinitis pigmentosa gene to chromosome 7q.
May 1993, Nature genetics,
Copied contents to your clipboard!